Atomistic Insights

What it does

Drug discovery teams are stuck with tools that take a year to reveal protein dynamics, missing new medicines. Our proprietary AI platform transforms what takes the status quo a year into just two days—exposing hidden binding sites that traditional methods miss. Founded by PhDs from Georgia Tech, we’re already partnered with one biotech and advancing six more. We are redefining what’s druggable and expanding the frontiers of therapeutic discovery.